Precept Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,100
| Closed | -$4.94M | – | 48 |
|
|
2021
Q4 | $4.94M | Hold |
13,100
| – | – | 1.94% | 7 |
|
|
2021
Q3 | $5.41M | Hold |
13,100
| – | – | 2.52% | 5 |
|
|
2021
Q2 | $4.85M | Sell |
13,100
-900
| -6% | -$333K | 2.04% | 7 |
|
|
2021
Q1 | $4.06M | Sell |
14,000
-76,000
| -84% | -$22M | 2.77% | 8 |
|
|
2020
Q4 | $22.5M | Buy |
90,000
+5,000
| +6% | +$1.25M | 9.11% | 1 |
|
|
2020
Q3 | $19.2M | Buy |
85,000
+7,700
| +10% | +$1.74M | 4.72% | 2 |
|
|
2020
Q2 | $13.5M | Buy |
77,300
+75,000
| +3,261% | +$13.1M | 2.58% | 4 |
|
|
2020
Q1 | $290K | Sell |
2,300
-27,800
| -92% | -$3.51M | 0.04% | 61 |
|
|
2019
Q4 | $4.6M | Buy |
30,100
+7,600
| +34% | +$1.16M | 2.22% | 12 |
|
|
2019
Q3 | $2.98M | Hold |
22,500
| – | – | 1.79% | 11 |
|
|
2019
Q2 | $3.19M | Buy |
22,500
+2,500
| +13% | +$355K | 1% | 15 |
|
|
2019
Q1 | $2.91M | Buy |
+20,000
| New | +$2.91M | 1.31% | 16 |
|